Statistics from Altmetric.com
V Jelic, M Kivipelto, B Winblad. Clinical trials in mild cognitive impairment: lessons for the future (J Neurol Neurosurg Psychiatry 2006;77:429–38).
In table 1 the column with heading Galantamine study 1 (GAL-INT-11) and row with heading ApoE e4, 26.4% galantamine, 29.5% placebo should be 45% galantamine, 47% placebo.
In table 1 the column with heading Galantamine study 2 (GAL-INT-18) and row with heading ApoE e4 24.4% galantamine, 23.5% placebo should be 42% galantamine, 41% placebo.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.